BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8336318)

  • 21. Monoclonal rheumatoid factor (IgG lambda) its association with amyloid deposits containing lambda light chains.
    Singh G; Myerowitz RL; Chervenick PA; Kelly RH
    Arch Pathol Lab Med; 1981 Nov; 105(11):586-9. PubMed ID: 6794541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An unusual cause of progressive heart failure.
    Sinha MK; Lachmann HJ; Kuriakose B; Abdulla AK; Aggarwal RK
    Lancet; 2001 May; 357(9267):1498. PubMed ID: 11377603
    [No Abstract]   [Full Text] [Related]  

  • 23. Globular amyloid deposits isolated to the small bowel: a rare association with AL amyloidosis.
    Hemmer PR; Topazian MD; Gertz MA; Abraham SC
    Am J Surg Pathol; 2007 Jan; 31(1):141-5. PubMed ID: 17197930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Light chain deposition disease].
    Sčudla V; Minařík J; Pika T
    Vnitr Lek; 2012 Jan; 58(1):38-43. PubMed ID: 22448699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease.
    Kaplan B; Livneh A; Gallo G
    Br J Haematol; 2007 Mar; 136(5):723-8. PubMed ID: 17223908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acquired cutis laxa associated with monoclonal gammopathy and lambda light chain deposition disease].
    Gonzalez-Rodriguez AJ; Bella-Navarro R; Ramon Quiles D; Jorda-Cuevas E
    Dermatol Online J; 2014 May; 20(5):22611. PubMed ID: 24852771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies.
    Bindi G; Smith A; Oliveira G; Eccher A; Vatrano S; Alberici F; Cazzaniga G; Galimberti S; Capitoli G; Magni F; Pagni F; L'Imperio V
    J Clin Pathol; 2024 May; 77(6):402-410. PubMed ID: 36813560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
    Ronco P; Plaisier E; Mougenot B; Aucouturier P
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulmonary diseases and non-amyloid light chain deposition].
    Colombat M; Stern M
    Rev Mal Respir; 2013 Sep; 30(7):524-6. PubMed ID: 24034455
    [No Abstract]   [Full Text] [Related]  

  • 31. [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma].
    Rekhtina IG; Zakharova EV; Stolyarevich ES; Sinitsina MN; Denisova EN
    Ter Arkh; 2015; 87(6):98-101. PubMed ID: 26281203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pseudo-hypertrophic pelvi-crural amyloid myopathy in lambda light-chain myeloma. Clinical, morphological and immunocytochemical study].
    Pellissier JF; Aquilina C; Murisasco A; Toga M
    Rev Neurol (Paris); 1987; 143(2):128-36. PubMed ID: 3110902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic lambda light-chain deposition presenting with predominant cardiac involvement.
    Garton MJ; Walton S; Ewen SW
    Postgrad Med J; 1993 Jul; 69(813):588-91. PubMed ID: 8415352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary manifestations of light chain deposition disease.
    Rho L; Qiu L; Strauchen JA; Gordon RE; Teirstein AS
    Respirology; 2009 Jul; 14(5):767-70. PubMed ID: 19659654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An unusual cause of cystic lung disease: light chain deposition disease].
    Luraine R; Sohier L; Kerjouan M; Desrues B; Delaval P; Jouneau S
    Rev Mal Respir; 2013 Sep; 30(7):567-71. PubMed ID: 24034462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.
    Pozzi C; D'Amico M; Fogazzi GB; Curioni S; Ferrario F; Pasquali S; Quattrocchio G; Rollino C; Segagni S; Locatelli F
    Am J Kidney Dis; 2003 Dec; 42(6):1154-63. PubMed ID: 14655186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Organ-specific nodular pulmonary amyloidosis of the A lambda type in Sjogren syndrome].
    Schneider F; Linke RP; Albrecht HJ
    Z Arztl Fortbild (Jena); 1997 Jan; 90(8):719-23. PubMed ID: 9133112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation.
    Weichman K; Dember LM; Prokaeva T; Wright DG; Quillen K; Rosenzweig M; Skinner M; Seldin DC; Sanchorawala V
    Bone Marrow Transplant; 2006 Sep; 38(5):339-43. PubMed ID: 16862166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathological atlas of renal diseases: light chain deposition disease.
    Ferrario F; Rastaldi MP
    J Nephrol; 2005; 18(5):499-502. PubMed ID: 16299674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.
    Vidal R; Goñi F; Stevens F; Aucouturier P; Kumar A; Frangione B; Ghiso J; Gallo G
    Am J Pathol; 1999 Dec; 155(6):2009-17. PubMed ID: 10595931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.